Attached files
| file | filename |
|---|---|
| EX-5.1(B) - EXHIBIT 5.1(B) - Synthetic Biologics, Inc. | tv504500_ex5-1b.htm |
| EX-5.1(A) - EXHIBIT 5.1(A) - Synthetic Biologics, Inc. | tv504500_ex5-1a.htm |
| EX-4.4 - EXHIBIT 4.4 - Synthetic Biologics, Inc. | tv504500_ex4-4.htm |
| EX-1.1 - EXHIBIT 1.1 - Synthetic Biologics, Inc. | tv504500_ex1-1.htm |
| S-1/A - S-1/A - Synthetic Biologics, Inc. | tv504500_s1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Synthetic Biologics, Inc.
Rockville, Maryland
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our reports dated February 22, 2018 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of Synthetic Biologics, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
McLean, Virginia
October 10, 2018